At a glance
ClinicalIndex Comparison RecordN/AActive· 250 enrolled
Drug / intervention
GORE® TAG® Thoracic Branch Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
In Brief
A clinical study evaluating GORE® TAG® Thoracic Branch Endoprosthesis for Aortic Aneurysm, Thoracic and Aorta; Lesion. Active but no longer recruiting, targeting 250 participants across 35 sites.
Detailed Summary
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta, requiring Zone 2 proximal implantation of the device.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Thoracic, Aorta; Lesion
CountriesUnited States
Collaborators--
Timeline
N/AActive
201720182019202020212022202320242025202620272028
First PostedMay 2016
Enrollment StartSep 2016
Primary CompletionApr 2021
TodayJul 2026
Study CompletionDec 2027
First PostedMay 19, 2016
Enrollment StartSep 6, 2016
Primary CompletionApr 12, 2021
Study CompletionDec 1, 2027
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 10.1 years ago
Interventions
GORE® TAG® Thoracic Branch Endoprosthesisdevice
Endovascular repair with the TBE Device